Effect of anlotinib combined with camrelizumab on clinical efficacy and short-term prognosis in male patients with advanced gastric cancer

This study aimed to investigate the effects of combining anlotinib with camrelizumab on clinical efficacy and short-term prognosis in male patients with advanced gastric cancer. A total of 88 male patients admitted to our hospital between May 2019 and March 2022 with advanced gastric cancer were...

Full description

Bibliographic Details
Main Authors: Tianliang Xu, Yusi Cheng, Yaping Wu, Rong Gong, Jie Hu, Qundi Duan
Format: Article
Language:English
Published: MRE Press 2023-05-01
Series:Journal of Men's Health
Subjects:
Online Access:https://oss.jomh.org/files/article/20230530-29/pdf/JOMH2023022201.pdf